Ganymed Pharmaceuticals GmbH
Quick facts
Phase 1 pipeline
- Claudiximab · Other
- IMAB027
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies